Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 22, 2022

50715_rns_2022-07-22_d995a1a7-9389-4bff-9cb1-74b7177254d2.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

22 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date os Descriptionf relevantecurities Descriptionof products Nature ofdealings Number ofreferencesecurities towhich thederivativesrelate Maturity date/ closing outdate Referenceprice Total amountpaid / received Resultantbalance(includingthose of anyperson withwhom there isan agreementorunderstanding)
CICC FinancialTrading Limited 21 July 2022 Derivatives Other types ofproducts Entering into of aderivative contract 330 25 July 2023 $40.9500 $13,513.5000 354
Derivatives Other types of Entering into of a 330 25 July 2023 $40.9250 $13,505.2500 354
products derivative contract

End

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Note:

CICC Financial Trading Limited is an exempt principal trader connected with the Offeror.

Dealings were made for its own account.

CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.

The other types of securities refer to Vanguard FTSE Emerging Markets ETF (VWO US Equity, ISIN US9220428588), which contains more than 1 percent share capital of 1171.HK, and price per unit is in USD.